No limits of its use with any patient.
The efficiency and results are key to success.
Only the rapid test is needed and nothing else.
No needed special store.
Simultaneous monitoring of IgM and IgG.
Easy to operate, and is compatible with serum/ whole blood/ plasma.
Serology test such as immunochromatography rapid test is highly recommended in combination use of nucleic acid test in COVID-19 because:
The COVID-19 coronavirus misdiagnosis is a huge concern due to many reasons and more likely happens if only rely on single PCR test result
The PCR/molecular tests require much higher standard and facilities to perform from both safety and quality perspectives. It becomes the major bottleneck to test suspected cases (can be large in some countries) in time.
Shortage of test performed will lead to potential mass infection events in terms of COVID-19. Serology test may also function as markers for prognosis, virus tracing and epidemiology study.
|Clinical diagnostic results||Nucleic acid test results|
|Confirmed Diagnosis||Exclusion||Positive (+)||Negative (-)|
|Total reagent results||Positive (+)||184||11||120||75|
|Total of Samples||570||570|
Sensitity: 91.54%; Specificity: 97.02%; Total clinical coincidence rate: 95.09%